FIGURE

Fig. 1

ID

ZDB-FIG-240315-35

Publication

Töpf et al., 2024 - Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy

Other Figures

All Figure Page

Back to All Figure Page

Fig. 1

Pedigrees of the SRPK3/TTN myopathy families.

a, Segregation of the familial SRPK3 variants is shown. S indicates the SRPK3 variant and WT indicates the wild-type allele. Individuals presenting with skeletal muscle disease are indicated in black. Mild presentations are shown in gray (corresponding to YIII:4 and YIII:5, two female carriers with skewed X-inactivation, 80:20 and 65:35, in lymphocytes, respectively). b, Extended pedigree details of families M and Z. Individuals presenting with skeletal muscle disease are indicated in black. Cardiac involvement is indicated by gray/dotted symbols. Segregation of the familial SRPK3 (S) and TTN (T) variants is shown. S + T indicates cosegregating SRPK3/TTN variants; WT indicates both SRPK3 and TTN WT alleles. Individuals ZIV:1, ZIV:4, ZIV:6 and ZIV:7 carry the familial TTN variant (p.Arg16905*) previously reported in association with DCM (ref. ¹⁹) but are presymptomatic at ages 52, 44, 40 and 38 years old, respectively. Likewise, individual MIII:2 carries the familial TTN variant (p.Asp28805Metfs*6) but is also presymptomatic at age 46 years old. c, Cosegregation of the SRPK3 and TTN variants (S + T) with the myopathic phenotype (shown in black). All known genotypes are shown; WT, both SRPK3 and TTN WT alleles; empty symbols indicate that the sample was not available for testing (or failed testing). All affected individuals carry the SRPK3 and TTN variants (S + T), whereas their unaffected relatives carry one or the other, but never both. Two females carrying cosegregating SRPK3/TTN variants and showing a skewed X-inactivation pattern are mildly affected (YIII:4 and YIII:5), and those with random X-inactivation are unaffected (TI:2, UI:2, XII:2 and YII:2). A female carrying only the SRPK3 variant (but no TTN variant; ZII:5) and a complete X-inactivation pattern (3:97, in lymphocytes) is unaffected. Individual RI:2, with cosegregating SRPK3 and TTN variants whose fully inactivated chr X carries the SRPK3 deleterious variant, is also unaffected. Individuals RII:3 and SI:2 are noninformative for the CAG repeat analyzed in the X-inactivation assay.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nat. Genet.